Transcript Highlights:

• This is similar to our drug offender probation.
• Catherine Shea, and schedule a field ride.
• over 50 drug offender cases.
• over 50 drug offender cases.
• Drug test.

Summary: The Criminal Justice Subcommittee heard an informational presentation from the Florida Department of Corrections on how the prison and community supervision systems operate after sentencing. Assistant Deputy Secretary Hope Gartman described the reception process for new inmates, including intake, medical and mental health screening, classification, custody and housing levels, gain time, and the department’s academic, vocational, substance abuse, chaplaincy, visitation, and communication programs. She emphasized that reentry begins on day one and that program placement is driven by risk and needs assessments, with facilities matched to inmates’ medical, mental health, and security requirements. Members also asked about family contact, visitor applications, inmate welfare trust funds, tablet access, private prison placement, staffing shortages, overtime, contraband interdiction, and waiting lists for programs; several follow-up materials were requested for distribution to all members. Mr. Winkler then outlined community corrections, explaining the different supervision types under Florida law, including probation, drug offender probation, community control, sex offender supervision, conditional release, and addiction recovery supervision. He described the department’s monitoring tools, such as office and field visits, warrantless searches, alternative sanctioning for technical violations, telephone reporting for low-risk offenders, employment assistance, and mobile probation and reentry units. He said the department’s supervision success rate is about 62%, with more than 91% of successful completers not returning to custody within three years. Members questioned officer workloads, the use of radios and GPS check-ins, the rollout of uniforms and firearms, how violations are handled, and whether all circuits participate in alternative sanctioning; Winkler said the program is statewide and that the department is seeking funding for radios. During public comment, Florida Cares Charity urged the committee to consider evidence on deterrence, parole, and recidivism, arguing that community supervision is less costly than incarceration and can be effective. James Beardy of the Florida PBA emphasized the dangers faced by correctional and probation officers, including long shifts, field searches, and working alone, and argued for higher pay and better support comparable to other law enforcement. The meeting concluded with the chair thanking the presenters and public speakers, and the subcommittee adjourned without taking any legislative votes or formal actions.

Transcript Highlights:

• Up next is the drug takeback fee setting and expenditures proposed final report.
• Our next JLARC meeting is scheduled for Wednesday, July 15th.
• Our next JLARC meeting is scheduled for Wednesday, July 15th.
• Our next J-LARC meeting is scheduled for Wednesday, July 15th.
• Our next J-LARC meeting is scheduled for Wednesday, July 15th.

Keywords: 904, all

Summary: At the April 8, 2026 JLARC meeting, members approved the January 7 minutes and recognized Marilyn Richter for more than 12 years of service to JLARC and the Citizens Commission. Staff then gave a legislative recap and work plan update, noting that JLARC staff presented to five committees during session, six bills or budget provisos implementing prior recommendations were enacted, and seven new study assignments were received. Members approved the updated 2025–2027 biennial work plan, including the new studies and the required 2027 lodging tax review. The committee also heard a presentation on a new post-meeting member survey tied to JLARC performance measures. Members then considered the final report on ignition interlock device compliance and monitoring. Staff reported that many drivers required to install ignition interlock devices do not do so, with installation rates rising with income, and identified problems in the Department of Licensing’s financial assistance program and coordination with the State Patrol. Both agencies said they concurred with JLARC’s recommendations to clarify responsibilities, formalize coordination, and develop a plan to increase installation rates. The committee approved the final report. Next, JLARC reviewed the final report on drug takeback fee setting and expenditures. Staff concluded that the Department of Health’s fee design limits full cost recovery and that the agency should publicly report oversight costs and activities; the legislature should revise the fee structure to better align with best practices. Members discussed whether the program should remain at DOH or be housed elsewhere, and adopted committee comments emphasizing transparency and future sunset review work before approving the final report. Finally, staff presented the scope and objectives for the Clean Buildings Performance Standard study, focusing on state-owned Tier 1 buildings and K-12 facilities in the first compliance cohort, with questions centered on compliance costs, energy savings, funding sources, fines, and possible workforce or budget impacts. The meeting ended with administrative announcements about upcoming meetings and adjournment.

Transcript Highlights:

• Green, who is an expert in community-based drug checking and drug testing.
• Green, who is an expert in community-based drug checking and drug testing.
• amount of drug.
• about drug checking.
• a drug checking service.

Keywords: 995, all

Summary: The Special Commission on xylazine held its first meeting, with House Chair Mindy Domb and Senate Co-Chair John Keenan outlining the commission’s charge and a proposed work plan. The commission is tasked with studying the public health and safety impacts of xylazine in the illicit drug supply, including whether it should be scheduled as a controlled substance, how to regulate its production and distribution, and how to improve outreach and treatment for people exposed to it. Members were told the report deadline had been extended to March 30, 2026, and staff proposed a series of public hearings and working groups leading to a final report. The meeting also included attendance, packet materials, and procedural planning. The first major testimony came from BSAS Director Deirdre Calvert, who described xylazine’s appearance in Massachusetts drug supply data, the state’s public health alerts, and DPH’s partnership with Brandeis, CDC, and harm reduction organizations. She emphasized four priorities: reducing stigma and discrimination in health care, expanding self-directed wound care support and coverage for supplies, expanding access to drug checking and test strips, and supporting low-barrier services such as mobile vans and drop-in centers. Commission members asked about first responder awareness, medical education, and whether harm reduction services might face federal restrictions; Calvert said misinformation remains a problem and noted ongoing training efforts, including collaboration with public safety agencies. Several other speakers reinforced the need for low-barrier care and drug checking. Dr. Raghini Jala, an infectious disease and addiction medicine physician, said xylazine has become a common component of the unregulated opioid supply and urged support for rapid-response education teams, community-based drug checking, and better hospital and detox protocols for xylazine withdrawal and wounds. Recovery coach Alan Young testified from lived experience, describing severe wounds, fear of inadequate withdrawal treatment in emergency settings, and the value of mobile care vans that can provide methadone, buprenorphine, and wound care in the community. Dr. Sarah Wakeman echoed the need for naloxone, rescue breathing, low-threshold treatment, and non-stigmatizing health care settings, while Sarah Macon of the Boston Public Health Commission described Boston’s harm reduction and drug checking work, including on-site testing, wound care, and a decline in opioid mortality. Tracy Green of the Massachusetts Drug Supply Data Stream explained that xylazine has declined in recent samples while metatomidine is rising, said drug checking is increasingly used but still not enough, and argued for more funding, staffing, and statewide access to real-time drug checking and harm reduction services.

Transcript Highlights:

• two very important preliminary reports: one on ignition interlock device compliance monitoring and drug
• This is a very tough scheduling time of the year for JLARC to meet, but it's also really important for
• This was initially scheduled to be in 2027.
• DOH’s oversight of the Drug Take-Back Program is carried out by 2.4 employees.
• The cost to administer the drug take-back program will remain approximately the same.

Keywords: 904, all

Summary: The Joint Legislative Audit and Review Committee met on January 7, 2026, approved the December minutes, and adopted an amended work plan. Staff proposed moving the drug take-back program sunset review up to 2026 and delaying the thermal energy network pilot review to 2028, which would free capacity for new studies. Members also discussed active bills that would eliminate two recurring JLARC reports, including one on lodging tax revenue data collection, and the committee adopted the work plan without objection. JLARC staff then outlined new performance measures for the committee itself, covering effectiveness, efficiency, and quality. The measures include member and legislative satisfaction surveys, presentations to other committees, recommendation follow-up, staff retention, on-time report delivery, peer review results, and national recognition. Members praised the effort and did not take formal action, treating the measures as an ongoing process. The committee also heard a proposal to improve JLARC’s review of tax preference performance statements by adding a standard rubric in fiscal notes to assess whether a metric matches the policy objective, is measurable, uses reliable data, and allows enough time for evaluation. Members supported the pilot approach. Staff also described planned changes to public records reporting guidance, including opt-outs for low-volume metrics, better validation, targeted outreach to nonreporting agencies, and a survey of records officers. Two preliminary reports were presented. On ignition interlock devices, JLARC found that only 41% of drivers with a requirement had installed a device, with installation rates rising sharply with income; financial assistance reaches only about 11% of users, and JLARC recommended clearer program goals and stronger coordination between the Department of Licensing and State Patrol. On the drug take-back program, JLARC found that the fee structure tied to operator expenditures limits the Department of Health’s ability to recover oversight costs and recommended public reporting of oversight spending and a statutory change to better align fees with actual costs. Agency representatives generally agreed with the findings, described current coordination and administrative changes, and said they would consider the recommendations. No formal votes were taken on the reports, which will return in final form later in the year.

Transcript Highlights:

• 2, Schedule 3, and Schedule 4 medications.
• Missouri PDMP only collects information, dispensation information on prescriptions for Schedule 2, Schedule
• 3, and Schedule 4 medications.
• And the total number of prescriptions for calendar year 2025, there were over 9 million Schedule 2, Schedule
• That being said, we're with Missouri now having a prescription drugs...

Keywords: 959, house, all

Summary: The Joint Committee on Administrative Rules met to consider Missouri PDMP rule 1 CSR 60-1.010 after the Department of Natural Resources withdrew its unrelated proposals. The hearing focused on a proposed expansion of access to the Prescription Drug Monitoring Program for additional behavioral health professionals, including licensed clinical social workers, licensed master social workers, marital and family therapists, professional counselors, and psychologists, along with related clarifications to delegate access. Supporters from the PDMP task force, Compass Health, and the Department of Mental Health argued the change would improve care coordination, medication reconciliation, and safety in multidisciplinary behavioral health settings, especially CCBHCs, and cited federal expectations that PDMPs be consulted in care planning. They also said access would remain limited to licensed Missouri professionals working under supervision or collaboration with prescribers or dispensers, and that misuse could be sanctioned. Committee members raised concerns about statutory authority, privacy, and whether the rule would substantially expand access beyond what the original PDMP legislation contemplated. Several members questioned whether the change should be made by statute rather than rule, whether it could be used for non-treatment purposes such as custody disputes, and whether the expansion would alter the character of the program. A chronic pain patient testified in opposition, warning that broader access could discourage patients from seeking counseling and could further burden people already affected by controlled-substance monitoring and prescribing restrictions. After public testimony, the committee debated the legality of the rule rather than its policy merits. A motion was made to disapprove the rule under RSMo 536.014 for lack of statutory authority, conflict with state law, and being arbitrary and capricious. The motion was supported by several members who said the change should go through the legislative process; one member opposed, arguing the rule was a practical extension of existing authority. On a roll call vote, the committee voted 7-1 to disapprove Rule 1 CSR 60-1.010, and the meeting adjourned.

Transcript Highlights:

• the heart of a conflict between federal and state law that deals with the disposal of prescription drugs
• Currently, these drugs in Schedule 4 or 5 and non-scheduled drugs, which is what we're trying to... .
• Currently, these drugs in Schedule 4 or 5 and non-scheduled drugs, which is what we're trying to...
• These drugs in Schedule 4 or 5 and non-scheduled drugs, which is what we're trying to focus on, which
• These drugs under state law need to be hand counted, even though that would be very impractical.

Summary: The Senate Committee on Health Policy considered several health-related measures. SB 890 on improving screening and treatment for blood clots was presented as a work-in-progress based on a prior working group. The bill would define certain clot-related conditions as chronic diseases, create a DOH registry, require screening and training in hospitals, nursing homes, and assisted living facilities, and several senators raised concerns about definitions, training requirements, facility responsibilities, and public records impacts. Survivors and family members testified in strong support, describing blood clots as a preventable public health crisis. The bill was reported favorably after a roll call vote. SB 668 on storage and disposal of prescription drugs and sharps would direct a study of medical sharps collection and address conflicts between state and federal law on disposal of certain prescription drugs. Senators discussed whether the study should include both individual and commercial disposal and whether newer injectable medications increase sharps waste. The bill received supportive testimony from waste and recycling stakeholders and was reported favorably. SB 762 on preventing the spread of avian influenza would create a DOH task force to develop a statewide response strategy, monitor outbreaks, study wastewater monitoring, and recommend cost-effective testing and prevention measures. An amendment extended the task force deadline, and the bill was reported favorably as a committee substitute. The committee also approved SB 182, which creates the Home Away From Home tax credit for businesses donating to charities that house families of critically ill children, with supporters saying it would help expand lodging for families in need. SB 942, the chair’s bill on restrictive covenants in health care, would limit non-compete clauses for physicians under a salary threshold, with debate focused on patient access, workforce retention, and concerns about small practices and contract enforcement. The bill was reported favorably. Finally, the committee adopted SPB 7018 to preserve a public records exemption for minors seeking judicial bypass of parental consent requirements for abortion, and then reported it favorably. Several members later recorded votes on earlier bills, and the committee adjourned.

Transcript Highlights:

• Ruth was living in a drug house with active drug users, plus all the undesirables coming in and out of
• When Ruth was born, she tested positive for drugs. We were not informed.
• It's not going to get better with drug-addicted parents. Thank you. Thank you for your testimony.
• I bring both lived experience as a drug-exposed infant with early CPS involvement and nearly 18 years
• Drug-affected newborns are being sent home to actively using parents with nothing more than the hope

Summary: The committee heard testimony on House Bill 2511, which would define “imminent physical harm” in the child welfare context as a substantial risk of serious harm arising from home conditions, caregiver conduct, neglect, substance abuse, unsafe environments, or other circumstances likely to cause significant injury. Representative Tom Dent, the sponsor, said the bill was intended to give caseworkers clearer tools to protect children while still recognizing the importance of keeping families together. Supporters, including some foster parents, kinship caregivers, advocates, and individuals with lived experience, argued that the current standard is too vague and has contributed to child fatalities and near-fatalities, especially in cases involving fentanyl exposure, chronic neglect, and abuse. They said clearer language would help courts and caseworkers intervene earlier and more consistently. Opponents, including legal aid, public defense, and child welfare policy groups, argued the bill is legally problematic, could conflict with existing statutes and ICWA-informed language, and would not address root causes such as service gaps, training, and inconsistent implementation. DCYF testified “other,” saying the bill could add clarity but that the language needed refinement; the sponsor said he was open to working on changes. No vote was taken on the bill during the hearing. The committee then heard House Bill 2660, which would allow courts at shelter care hearings to order parents of children under age five to comply with safety-related conditions, evaluations, or services when the child is returned home, with referrals required within seven days and participation not treated as an admission of abuse or neglect. The sponsor, Representative Ortiz-Self, said the bill is aimed at critical incidents and would give caseworkers and courts more ability to require safeguards for very young children when families are not voluntarily engaging in services. DCYF and the Office of the Family and Children’s Ombuds supported the bill, saying it could help prevent tragedies by allowing earlier court-ordered services and safety conditions. Some advocates and parents also supported it, describing cases where removal or court intervention helped protect children. Opponents, including public defense and some family-support organizations, raised constitutional and due process concerns, argued that services are not the same as immediate safety, and warned the bill could shift problems without fixing underlying service shortages. The sponsor and DCYF discussed the need for follow-up on language and implementation, but no committee action or vote was taken in the hearing.

Transcript Highlights:

• drugs? Are you using drugs or alcohol? And I guess they could say no and be lying.
• So, you see the drug spend in 2022 was... for just the top 10 drugs.
• Top Medicaid drugs.
• from moving on to a different drug and having coverage for that drug if, in fact, the preferred drug
• Preferred drug list to include the cheaper drugs. Yes, Madam Chair, that's correct.

Transcript Highlights:

• FDA and scheduled or rescheduled by the USDA is assigned to the identical schedule under the Controlled
• FDA and scheduled or rescheduled by the USDA to any schedule other than Schedule I under the Controlled
• FDA that was scheduled or rescheduled.
• FDA and scheduled or rescheduled by the USDA to the identical schedule under the Controlled Substances
• FDA, and scheduled or rescheduled by the USDA to any schedule other than Schedule 1 under the Controlled

Keywords: 1182, all

Summary: The committee heard a long series of Senate bills, mostly on third-read consent, covering education, public safety, health, courts, labor, and water. Several bills were briefly explained and then pulled from consent for further discussion, including measures on public records review standards (SB 1078), sexually explicit materials in schools/libraries (SB 1435 and SB 1567), burial costs in death cases (SB 1135), military flags in HOAs/COAs (SB 1184), court-ordered treatment guardianship (SB 1243), standardized state hiring (SB 1665), released-time religious instruction (SB 1741), firearm safety instruction in schools (SB 1424), student participation in extracurriculars after certain convictions (SB 1475), Celebrate Freedom Week (SB 1572), federal scholarship-granting organizations/vouchers (SB 1142), immigration-related arrest notifications (SB 1055), defamation standards (SB 1099), peace officer certification for military police veterans (SB 1107), mandatory reporting of child abuse/neglect directly to DCS (SB 1127), attorney licensing and discipline issues (SB 1148 and SB 1039), concealed weapons on college campuses (SB 1068), and firearm muffling devices/silencers (SB 1069). Members also raised constitutional, policy, and school-safety concerns on several of these bills, while supporters emphasized alternative pathways for students, veterans, and workers, and tighter reporting or licensing rules. Other bills were described without extended debate, including claims against the state for unpaid contracted services (SB 1097), workers’ compensation death benefits for surviving spouses who remarry (SB 1136), burial expense increases (SB 1135), state agency web pages for internal guidance (SB 1586), court-ordered treatment procedures and service of process in mental health cases (SB 1113), medical examiner authorization (SB 1123), tribal MOUs with DCS (SB 1125), controlled-substance scheduling conformity with federal classifications (SB 1188), EMT personal information protections (SB 1193), mammography notice updates (SB 1318), assisted-living referral disclosures (SB 1477), accommodation school GED instruction for 11th graders and students over 16 (SB 1166), credit enhancement board continuation (SB 1422), school district and charter school obligations related to religious release time (SB 1741), school firearm safety instruction (SB 1424), and school civics/freedom-week instruction (SB 1572). The committee also heard bills on CPA certification pathways (SB 1181), insurance adjuster licensing (SB 1415), county voter-registration rules online (SB 1040), campaign address privacy (SB 1259), federal land acquisition notification (SB 1281), water supply/demand assessments (SB 1202), environmental compatibility for power plants and small modular reactors (SB 1418), and groundwater recovery rules (SB 1785). The meeting ended with announcements and a brief recognition of Rep. Stephanie Hamilton with an “Affordability Award.” No final votes are shown in the transcript excerpt; instead, many bills were either left on consent, pulled for later discussion, or flagged for closed caucus. The chair then asked guests to leave so members could hold a closed caucus.

Transcript Highlights:

• Uh so, drugs, they can change drugs.
• Um, there's nothing in this bill that would prohibit diagnoses of Schedule I through Schedule IV drugs
• </c> addictive drugs. addictive drugs.
• of schedule one through schedule<03:01:27.680><c> four</c><03:01:28.000><c> drugs.
• </c> schedule four drugs. schedule four drugs.

Keywords: 1189, house, all

Transcript Highlights:

• under the North Dakota Schedule of Substances.
• That was the bill that would have placed kratom on a Schedule I substance.
• That was the one that would place it on as a schedule on substance.
• It’s a dangerous drug.
• It's a dangerous drug.

Summary: The working group met for a legislative-only discussion on kratom ahead of a special session, with members first hearing a staff memo summarizing federal and state regulation, kratom’s psychoactive effects, reported health risks, and North Dakota’s recent executive action and special session call. The chair explained that legislators in the room would speak first, then online participants, with comments limited to about five to seven minutes, and noted a public open house and later expert testimony would follow. Several legislators argued the issue had already been extensively debated in the 2025 session, citing House Bill 1101, which would have scheduled kratom as a Schedule I substance and was defeated, and House Bill 1566, which evolved into a study. They urged the group to consider both prohibition and regulation, and some suggested a temporary measure until the 2027 session. Others emphasized testimony from people who say natural kratom helps with chronic pain or PTSD and warned against banning a product that some use to function, while still supporting tighter controls on adulterated or synthetic products. Other members focused on public health and enforcement concerns. Some said the executive order created confusion for users, retailers, and law enforcement, and raised concerns about withdrawal, access to treatment such as Suboxone, and whether the state could regulate the product effectively in the short time available. A pharmacology-focused discussion distinguished natural kratom leaf from synthetic 7-OH products, with several members saying the synthetic forms pose the greatest overdose risk and should be tightly restricted or scheduled, while any legal natural product would need strict limits, labeling, and penalties. The meeting ended without a vote, with the chair saying the group would continue gathering testimony and return for further hearings next week and during the special session.

Transcript Highlights:

• I drug to get that kind of authorization and funding.
• We also believe that the bill could be premature because FDA-approved drugs are coming soon.
• The first bill is Senate Bill 5916 concerning non-opioid drugs for the treatment of pain.
• the covered entity uses 340B drug savings.
• HIV antiviral drugs before us, and there is a proposed substitute labeled S-4243.1.

Summary: The Senate Health and Long-Term Care Committee met on January 27 and heard extensive public testimony on several bills before moving into executive session. Senate Bill 5921 would create a Department of Health medical psilocybin program for adults with qualifying conditions, with licensed producers and clinician participation requirements, training, background checks, and program standards. Supporters, including the sponsor and many clinicians, veterans, first responders, and patients, described psilocybin as promising for treatment-resistant depression, PTSD, trauma, and end-of-life anxiety, while opponents and some medical groups raised concerns about missing safeguards, contraindications, monitoring, cost, and the bill’s narrow medical model. Testimony was split sharply, with many also urging broader decriminalization or community-use protections. The committee later heard Senate Bill 6115, which would have the Department of Health contract for age-appropriate cancer education for grades 6-12; supporters from Cancer Pathways, educators, and families said it would improve prevention and risk awareness, while the bill drew substantial opposition in sign-in counts, and the hearing was ultimately closed without action that day. The committee also heard Senate Bill 5185, a pilot pathway for international medical graduates to obtain full unrestricted primary care licensure after supervised clinical practice, completion of exam and competency requirements, and annual reporting. The sponsor, Washington Medical Association, the Medical Commission, and IMG advocates said the proposal would expand access to primary care while maintaining patient safety, and the bill received supportive testimony. In executive session, the committee adopted proposed substitutes and advanced Senate Bill 5916 on non-opioid pain drugs, Senate Bill 5985 on endometriosis, Senate Bill 6019 on home care rate statutes, Senate Bill 6161 on dementia information, and Senate Bill 6183 on HIV antiviral drug coverage. For Senate Bill 5981 on the 340B drug pricing program, the committee adopted an amendment adding reporting and transparency requirements before moving the bill forward. The committee then adjourned, and the remaining hearing items were rescheduled for a later date.

Transcript Highlights:

• This preference was enacted in 2016 and scheduled to expire December 31, 2037.
• This preference was enacted in 2017, and it's scheduled to expire January 1, 2028.
• Drug manufacturers fund this program, and manufacturers pay program operators to implement the drug take-back
• JLARC is scheduled to conduct a more comprehensive sunset review of the program in 2027.
• The Drug Take Back Program The drug take-back program is scheduled to sunset on January 1, 2029, unless

Summary: The meeting began with JLARC’s biennial executive committee elections. After confirming a quorum, members unanimously elected Representative Pollet as chair, Senator Wagoner as vice chair, Representative Orcutt as secretary, and Senator Solomon as assistant secretary for the 2025-27 biennium. The committee also approved the May 14 meeting minutes unanimously. Chair Pollet then outlined a commitment to more member input on audit scope and coordination with the State Auditor’s Office. Staff presented a preliminary report on Washington State recreation boating programs. They reported that six agencies administer boating-related activities, that the state collected about $108 million in boating-related revenue in 2021-23, and that $86 million was spent, mostly on infrastructure and water access, environmental protection, boater safety, and marine law enforcement. Staff said Washington’s boating laws and programs are broadly similar to other states and noted that the final report is expected in September. JLARC then reviewed several tax preferences. For natural gas used as a transportation fuel, staff said the preferences reduce fuel costs but did not meet emissions-reduction targets because fewer vessels and vehicles converted to natural gas than expected; staff recommended continuing some exemptions and modifying reporting requirements. For travel agents and tour operators, staff said the preference continues to provide tax relief, but large beneficiaries’ savings are rising while small beneficiaries’ use is declining, leading to recommendations to continue the small-business rate and add or revise performance metrics. Staff also reviewed a nonprofit low-income housing property tax exemption, concluding it helps developers build homes as intended but that the performance metric should better reflect housing outcomes; they recommended the legislature decide whether to continue or modify it. Other reviews covered multipurpose senior citizen centers, disabled veteran adapted housing, trade convention attendance, agricultural fertilizer and seed wholesaling, hazardous substance tax treatment for pesticides, and silicon smelter energy preferences, with recommendations ranging from continuation to expiration depending on whether the stated objectives were met. The committee then adopted the final cannabis market study for distribution. Staff reported that Washington businesses produced two to three times more cannabis than retailers sold in 2023, and that inaccurate and incomplete reporting limits the Liquor and Cannabis Board’s ability to regulate the market. The board said it concurs with the recommendations, including developing a plan for a new data system and considering broader social equity options. Finally, staff presented the proposed final report on Department of Health oversight of hospital data reporting, inspections, and complaints. Staff said DOH was late on most acute-care hospital inspections, had not fully verified third-party inspection standards, and did not adequately review adverse event correction plans or assess language access barriers in its complaint system. DOH said it concurs with all six recommendations and has already made some transparency improvements, including a public dashboard for adverse event reporting.

Transcript Highlights:

• And uh also uh there's a bill being uh proposed to schedule uh Kratom as schedule two drug.
• And uh also uh there's a bill being uh proposed to schedule uh Kratom as schedule two drug.
• And uh also uh there's a bill being uh proposed to schedule uh Kratom as schedule two drug.
• And uh also uh there's a bill being uh proposed to schedule uh Kratom as schedule two drug.
• And uh also uh there's a bill being uh proposed to schedule uh Kratom as schedule two drug.

Bills: HF3771, HF3658, HF3453, HF3358, HF1775

Keywords: disaster assistance, contingency account, Minnesota emergency management, public safety, state disaster aid, FEMA, federal cost-share, emergency relief, natural disaster, budget report, appropriations report, management and budget, local governments, utility cooperatives, public works, infrastructure repair, chapter 12B, chapter 12A, emergency management, disaster recovery

Transcript Highlights:

• program designed to lower drug costs for patients.
• We do need lower costs of prescription drugs. We do need more affordable prescription drugs.
• drug, like that same actual drug, not the same type or quantity, but the same one, and then also receive
• The amendment does not address acquisition of drugs under the 340B drug pricing program.
• This is about taking the difference between a wholesale drug price and a retail drug price, where pharma

Bills: HB2720, HB2073, HB2487, SB5816, SB5919, SB5831, SB6137, SB6244, SB6044, SB6132, SB5109, SB5877, SB6258

Keywords: behavioral health, emergency services, health insurance, provider access, mental health funding, premium assistance, funding, healthcare, subsidies, insurance tax, state regulation, insurers, taxation, budget impact, juice grapes, agriculture, commerce, market access, fire safety, insurance incentives

Summary: The House took up and passed Second Substitute Senate Bill 5292, which modifies the paid family and medical leave program. Supporters said the bill uses an actuarial model to set rates and maintains a four-month reserve to improve program stability. It passed final passage 95-1. The House then considered Substitute Senate Bill 5841, dealing with completion of course and financial aid-related requirements. An amendment was adopted to add a financial aid calculator and require outreach to students who indicate they have completed a financial aid form, with supporters saying it would help students understand aid eligibility and access college opportunities. The bill then passed as amended, 92-4. The most extensive debate was on Engrossed Second Substitute Senate Bill 5981, concerning the 340B drug pricing program and contract pharmacy relationships. Members offered many amendments seeking to limit the bill’s scope, add transparency, or direct 340B savings toward patient care, low-income patients, rural areas, or charity care; most were rejected. Supporters argued the bill would help safety-net providers, hospitals, and FQHCs, while opponents warned it would mainly benefit large hospital systems, create administrative burdens, and likely face litigation. After the House adopted the committee amendment and rejected the floor amendments, the bill passed 67-30. The transcript then moved on to other business, including Senate messages and the start of debate on House Bill 2487 on taxes, with one technical amendment to clarify taxpayer definitions.

Transcript Highlights:

• two very important preliminary reports: one on ignition interlock device compliance monitoring and drug
• This is a very tough scheduling time of the year for JLARC to meet, but it's also really important for
• This was initially scheduled to be in 2027.
• DOH's oversight of the drug take-back program is carried out by 2.4 employees.
• The cost to administer the drug take-back program will remain approximately the same.

Summary: The Joint Legislative Audit and Review Committee met on January 7, 2026, approved the December minutes, and adopted an amended work plan. Staff proposed moving the drug takeback program sunset review up to 2026 and delaying the thermal energy network pilot review to 2028, which would free capacity for new studies. Members also noted bills that would eliminate two recurring JLARC reports, including one on unemployment insurance training benefits and one on lodging tax revenue reporting. The committee then discussed JLARC’s own performance measures and a pilot approach for evaluating tax preference performance statements in fiscal notes. Staff said JLARC will begin surveying members and the full legislature on satisfaction, track invitations to present to other committees, monitor recommendation resolution rates, staff retention, on-time report delivery, peer review results, and national recognition. For tax preference reviews, staff proposed a standard rubric to assess whether performance metrics match policy goals, are measurable, use reliable data, and allow enough time for evaluation; members generally supported the effort. Staff also outlined planned changes to public records reporting, including allowing agencies to opt out of tracking low-volume metrics, targeted outreach to nonreporting agencies, better data validation, clearer online guidance, and a survey of public records officers. The main audit presentation was a preliminary report on ignition interlock device compliance and monitoring. JLARC found that about 41% of drivers required to install devices had done so, with installation rates rising sharply with income; half of affected drivers earned less than $28,000 a year, and the typical annual device cost was about $2,700. Staff said the state’s financial assistance program has limited reach and lacks clear goals, performance measures, and coordination between the Department of Licensing and State Patrol. They recommended that the agencies formalize their roles and develop a coordinated strategy to improve installation rates. State Patrol and Licensing said they support the findings, described recent outreach pilots, and said they would work on a management plan and possible expansion of outreach efforts. JLARC also presented an expedited preliminary report on the drug take-back program’s fee setting and expenditures. Staff concluded that the current fee design limits the Department of Health’s ability to recover oversight costs and that public reporting of oversight expenditures would improve transparency. They recommended that DOH publicly report its oversight activities and that the legislature amend the fee structure to remove the cap tied to program operator expenditures. DOH agreed the current structure does not fully recover costs and said it would support a statutory change. The committee adjourned after noting its next regular meeting is scheduled for April 8, 2026.

Transcript Highlights:

• For the purpose of SB 758, the purpose is to restrict the sale of these dangerous drugs.
• Additionally, there are no FDA-approved drugs containing 7-OH, and it is illegal to market any drugs
• It's not a designer drug, nor a novel, lab-synthesized chemical being snuck into smoke shops.
• Aiden Moore, with Students for Sensible Drug Policy, and I oppose this bill.
• I drug to now just focusing on a misdemeanor for the sale and distribution. ...one drug to now just

Summary: The Senate Committee on Public Safety heard two bills. SB 99 by Senator Blakespear, sponsored by the U.S. Department of Defense, would improve coordination between civilian and military law enforcement in domestic violence cases involving military protective orders (MPOs). The bill would require courts to check for MPOs in the NCIC system when considering restraining orders, allow MPOs to be admissible evidence, require civilian officers to notify military law enforcement of possible MPO violations, and allow local agencies to enter MOUs with the military. Supporters said the bill would close jurisdictional gaps that can leave survivors unprotected; the ACLU opposed it unless amended, citing due process concerns because MPOs are issued by commanders without court process. The committee discussed amendments to make notification and MOU provisions less automatic and to broaden local agency participation, then passed SB 99 to Judiciary on a 5-0 vote. SB 758 by Senator Umberg, as amended, would make the sale or distribution of products with unnaturally concentrated 7-hydroxymitragynine (7-OH) a misdemeanor and would restrict nitrous oxide sales by tobacco retailers while preserving legitimate culinary and medicinal uses. Supporters, including local governments, law enforcement, and public safety advocates, described widespread misuse of nitrous oxide and 7-OH, especially among youth, and cited poisonings, injuries, and deaths. Opponents argued the bill would criminalize adults using kratom-related products for pain relief or harm reduction, questioned the scientific evidence, and urged a regulatory or public health approach instead of prohibition. Committee members largely agreed the issue raised public health questions and supported moving the bill forward with amendments; SB 758 passed to Appropriations on a 5-0 vote.

Transcript Highlights:

• And it came up with the minimums under a bond schedule.
• It's come up with the bond schedules for each of the 20 circuits.
• I fully support the state uniform bond schedule.
• Sometimes it's, the sheriff talked about the uniform bond schedule.
• I may have somebody who says, who's a drug user who says, I bought my drugs from Jack, but I'm never

Summary: The Criminal Justice Subcommittee held its first meeting of 2025, took roll, confirmed a quorum, and heard member introductions before turning to an informational panel on how a criminal case moves through Florida’s system. The chair emphasized respectful committee process and introduced staff, then invited the panel to explain the path from arrest through prosecution, first appearance, arraignment, discovery, trial, plea negotiations, and sentencing. Sheriff Bob Gualtieri described law enforcement discretion, probable cause, misdemeanor and felony arrest rules, pre-arrest diversion, jail operations, and the statewide uniform bond schedule. He also discussed jail overcrowding, supervised release, mental health and substance abuse issues in jails, and the need for better case management and diversion resources. Judge Frank Allman explained first appearance, bond setting, arraignment, trial procedures, plea colloquies, and sentencing under Florida’s punishment code, including downward departures and victim impact statements. State Attorney Jack Campbell outlined charging decisions, the higher proof burden prosecutors must meet, coordination with law enforcement, Baker Act proceedings, victim notification, informations versus grand jury indictments, and the role of diversion and treatment courts. Public Defender Matthew Mets described indigency screening, discovery, the growing volume and technical complexity of evidence, mitigation work, and the importance of treatment-based resolutions. Members asked about time-served credit for supervised release, mental health recidivism, homelessness enforcement, ICE holds, and sentencing discretion; no votes were taken and the meeting ended after the informational presentation and discussion.

Transcript Highlights:

• It is still a Schedule I drug.
• The president has indicated a desire to move that to Schedule III, but it remains currently a Schedule
• I drug.
• ODMAP is managed by the Washington-Baltimore High Intensity Drug Trafficking Area.
• We know we all know that we have a serious drug and overdose problem in this state.

Bills: HB2110, HB2113, HB2122, HB2152, HB2168

Keywords: ambulance, interfacility transport, specialty care transport, emergency medical services, EMS, registered nurse, nurse staffing, paramedic, emergency medical technician, EMT, patient transfer, hospital transfer, critical care transport, medical transport, workforce shortage, scope of practice, Department of Health, RCW 18.73, first responder, basic life support

Summary: The House Health Care and Wellness Committee heard public testimony on several bills. HB 2152 would require hospitals, nursing homes, and hospice facilities to allow qualifying terminally ill patients to use medical cannabis under facility policies that prohibit smoking/vaping, require patient self-administration and secure storage, and protect facilities from licensure consequences; the prime sponsor and supporters framed it as a compassionate end-of-life measure based on the experience of Ryan Bartel, while the Washington State Hospital Association asked for amendments to limit it to inpatient beds and to bar staff from retrieving cannabis. HB 2122 would require hospitals to offer flu vaccines to inpatients age 65 and older and to inpatients with chronic conditions during flu season; supporters cited rising flu deaths and benefits for high-risk patients, while opponents questioned the need and urged stronger informed-consent language, and hospitals raised cost and operational concerns. HB 2110 would relax staffing rules for inter-facility specialty care transports by allowing a registered nurse without EMT certification to serve when no paramedic or RN-EMT is available; rural hospitals and ambulance providers said the change would improve timely transfers, while nurses’ representatives raised concerns about training, medical oversight, and staffing impacts on hospital units. The committee also heard HB 2113, which would update supervision rules for radiologic technologists performing IV contrast procedures by allowing virtual direct supervision by a physician and direct supervision by an ARNP or PA for contrast administration, while keeping other parenteral procedures under physician supervision. Supporters said the bill would align state law with current practice and federal CMS rules and improve access in rural areas; radiology stakeholders supported the bill but asked for a proximity requirement for virtual physician supervision. Finally, HB 2168 would require the Department of Health to rapidly share overdose data from the EMS information system to ODMAP within 24 hours, with privacy protections and limits on law-enforcement use; supporters said it would improve near-real-time overdose response and save lives, while the Washington Poison Center asked to be added as a data source and to clarify the bill’s overdose terminology. No votes were taken, and the meeting adjourned after public hearings.

Transcript Highlights:

• In order to dispense the drugs to patients, many covered entities use an arrangement wherein the drugs
• , restrict, or prohibit the acquisition of a 340B drug by or delivery of a 340B drug to a covered entity
• Because the drug maker is required to sell the drug at a discount, when we purchase the drug as a self-funded
• When the drug flows through 340B, because the drug maker is already required to provide a substantial
• Hospitals buy drugs at steep discounts, and our employees with high-deductible plans are... ...buy drugs

Summary: The Ways and Means Committee held a public hearing on multiple bills, beginning with a motion to suspend the five-day notice rule for a long list of Senate bills, which passed on a voice vote. The committee first heard Substitute Senate Bill 6026, a governor-request housing bill that would require cities and counties over 30,000 population to allow residential uses in commercial and mixed-use zones, limit mixed-use/ground-floor commercial requirements in some areas, and allow added height where such requirements are imposed. The lieutenant governor testified strongly in support, arguing the bill would add needed housing capacity without requiring ground-floor retail burdens. The hearing on SB 6026 was then suspended so the committee could move through the agenda. The committee then heard Senate Bill 6294, a broad local government finance measure with eight parts, including expanded uses for certain REET revenues, a new county public utility tax, a new local sales tax for children and family services, expanded housing-related tax uses, changes to county levy structure, longer lid lift periods, and expanded use of rental car tax revenue. Local government, housing, and public health witnesses largely supported the bill, emphasizing flexibility for affordable housing, rental assistance, children’s services, and county fiscal stability. Opponents, including wireless industry, water/sewer district, auto dealer, realtors, energy, and cannabis representatives, objected to specific tax provisions as regressive, costly, or likely to raise consumer prices. Several witnesses requested amendments, including adding public health clinic funding and flood recovery language from House bills. The committee also heard Substitute Senate Bill 5400 on local news sustainability, which would create a state grant program funded by a surcharge on large search engines and social media platforms to support journalism jobs and the Murrow Fellowship program. News organizations, the League of Women Voters, open government advocates, and local journalism supporters testified in favor, saying local news is essential to civic life and that the bill would help sustain reporting without using general fund dollars. Technology industry representatives opposed the bill, arguing it unfairly singles out tech companies and could face legal challenges. The committee then heard Senate Bill 6211, which would let opt-in GMA jurisdictions impose REET-2 without voter approval; cities and counties supported it as a parity and infrastructure funding measure, while Realtors opposed the loss of voter approval. Senate Bill 5650, authorizing local cannabis excise taxes, drew support from some local officials but strong opposition from cannabis businesses, which argued Washington’s cannabis taxes are already too high and drive sales to the illicit market. Senate Bill 6033, waiving penalties and interest for taxpayers who failed to collect new sales tax on certain services, was supported by NFIB as a compliance and fairness measure. Senate Bill 6297, exempting temporary staffing services for nonprofit behavioral health providers from sales tax, drew strong support from behavioral health organizations citing workforce shortages and unsustainable costs. Finally, Senate Bill 6343, extending and expanding tax relief for disaster-damaged property and repairs, was presented as aid for flood recovery; local officials testified in support. No final committee votes on the bills were taken in the portion of the meeting provided.